Can't imagine the market not being confident. The recent licensing deal is a pretty clear sign that those who are far more knowledgeable than most ASX investors see great potential here. Usually the US is the most lucrative market for new drugs, so the fact they've scored this quite impressive deal which doesn't even include the US is a strong signal of the potential here. Once we have the data, I can't see how we don't score a US deal many multiples larger than the recent one
My view is simply the market is not recognising what we have yet. This is not exactly uncommon, especially for lower MC stocks there just isn't a lot of research. Not sure what will cause this to change, perhaps FOMO will arrive closer to the readout or the announcement itself will trigger the buying... who knows
-
- There are more pages in this discussion • 506 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
0.020(3.74%) |
Mkt cap ! $333.0M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 56.5¢ | 53.5¢ | $448.6K | 815.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4032 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.5¢ | 7370 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| DXB (ASX) Chart |